What is the main business of Hovet Dystrybucja?

The main business activity of Hovet Dystrybucja focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 15, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Leśna 26, 21-100 Lubartów.

Who is on the management board?

The management board consists of: Piotr Dardziński (Member of the Management Board) and Zbigniew Siwiec (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $17,105 in 2024.

No, the company recorded a net loss of $1,308 in 2024. For comparison, in 2023 the loss was $1,587, meaning the company reduced its loss by 21.7%.

Which cost dominates operating expenses?

The largest operating cost category falls under materials and energy. This category amounted to $18,413 in 2024, representing 100% of all operating expenses.

Hovet Dystrybucjasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-05-15

Share capital

10 000,00 PLN

Registered address

ul. Leśna 26, 21-100 Lubartów, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

2025not filed
202401/07/2025
202326/06/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 17.10kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD -1.31kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 18.41kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 296.54MedianUSD 609.79kAverageUSD 11.85m

Industry

Wholesale of pharmaceutical goods (46.46.Z)Primary

Authorized Representatives

Piotr Dardziński – Management Board Member

Zbigniew Siwiec – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Piotr Dardzińskiage 67	100	$1,350.62	50%
Zbigniew Siwiecage 65	100	$1,350.62	50%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o.	$600,815,720.02	slawex.com.pl
LubfarmS.A.	$123,208,945.21	lubfarm.pl
Camedica Paweł Harasimiuksp. k.	$18,691,613.15	camedica.pl
Medcomplexsp. z o.o.	$5,193,830.09	medcomplex.pl
Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o.	$4,277,670.93	cezal.lublin.pl
Bio-Novumsp. z o.o.	$3,459,663.10	bio-novum.com
Myderm Laboratoriessp. z o.o.	$177,750.48	myderm.com.pl
GROW Pharmasp. z o.o.	$15,020.86	growpharma.pl
PetnovellS.A.	$0.00	petnovell.pl
Dental Łukasiksp. j.	–	dental.lublin.pl